GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » HOB Biotech Group Corp Ltd (SHSE:688656) » Definitions » EV-to-EBITDA

HOB Biotech Group (SHSE:688656) EV-to-EBITDA : 24.46 (As of Jun. 25, 2024)


View and export this data going back to 2021. Start your Free Trial

What is HOB Biotech Group EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, HOB Biotech Group's enterprise value is ¥1,403.2 Mil. HOB Biotech Group's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ¥57.4 Mil. Therefore, HOB Biotech Group's EV-to-EBITDA for today is 24.46.

The historical rank and industry rank for HOB Biotech Group's EV-to-EBITDA or its related term are showing as below:

SHSE:688656' s EV-to-EBITDA Range Over the Past 10 Years
Min: 16.93   Med: 35.08   Max: 61.89
Current: 24.46

During the past 8 years, the highest EV-to-EBITDA of HOB Biotech Group was 61.89. The lowest was 16.93. And the median was 35.08.

SHSE:688656's EV-to-EBITDA is ranked worse than
71.19% of 479 companies
in the Medical Devices & Instruments industry
Industry Median: 15.22 vs SHSE:688656: 24.46

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-25), HOB Biotech Group's stock price is ¥23.14. HOB Biotech Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.710. Therefore, HOB Biotech Group's PE Ratio for today is 32.59.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


HOB Biotech Group EV-to-EBITDA Historical Data

The historical data trend for HOB Biotech Group's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HOB Biotech Group EV-to-EBITDA Chart

HOB Biotech Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial - - 28.41 23.36 21.12

HOB Biotech Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 58.55 46.31 53.82 21.12 28.24

Competitive Comparison of HOB Biotech Group's EV-to-EBITDA

For the Medical Devices subindustry, HOB Biotech Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HOB Biotech Group's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, HOB Biotech Group's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where HOB Biotech Group's EV-to-EBITDA falls into.



HOB Biotech Group EV-to-EBITDA Calculation

HOB Biotech Group's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=1403.178/57.374
=24.46

HOB Biotech Group's current Enterprise Value is ¥1,403.2 Mil.
HOB Biotech Group's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥57.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HOB Biotech Group  (SHSE:688656) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

HOB Biotech Group's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=23.14/0.710
=32.59

HOB Biotech Group's share price for today is ¥23.14.
HOB Biotech Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.710.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


HOB Biotech Group EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of HOB Biotech Group's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


HOB Biotech Group (SHSE:688656) Business Description

Traded in Other Exchanges
N/A
Address
No. 218 Xinghu Road, Suzhou Industrial Park, C10 Building, Jiangsu, Suzhou, CHN, 215123
HOB Biotech Group Corp Ltd is an in vitro diagnostic company. The firm is specialized in providing diagnostic tools to laboratories and hospitals for the improvement of allergy and autoimmune disease patient care.

HOB Biotech Group (SHSE:688656) Headlines

No Headlines